Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

TECX

Tectonic Therapeutic, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • TECXTectonic Therapeutic
    0Calm

    A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

    Running, no new patientsPhase 2191 patientsMain results: Nov 24, 2026

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

4 sales (0 not pre-planned) · 0 purchases

  • McNamara PeterChief Scientific Officer · Sep 30, 2026Sold 536 sharesabout $12 thousand · pre-planned
  • McNamara PeterChief Scientific Officer · Aug 25, 2026Sold 43 sharesabout $2 thousand · pre-planned
  • McNamara PeterChief Scientific Officer · Aug 12, 2026Sold 43 sharesabout $2 thousand · pre-planned
  • McNamara PeterChief Scientific Officer · Jun 30, 2026Sold 172 sharesabout $6 thousand · pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Nov 5, 2026
  • News reportNews report (8-K)Nov 5, 2026
  • Other newsNews report (8-K)Sep 29, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 6, 2026
  • Shared quarterly resultsNews report (8-K)Aug 6, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Other news
News report (8-K)
Jun 10, 2026